What You Should Know:
– SimonMed Imaging, one of the largest and most advanced outpatient medical imaging providers in the United States, announced a significant partnership with Lunit, a global leader in AI-driven cancer diagnostics and therapeutics.
– The collaboration aims to bring a new era of artificial intelligence (AI)-powered breast cancer detection to patients across SimonMed’s extensive network, marking a major milestone in the company’s mission to save lives through early detection.
Selecting Advanced AI for Personalized Screening
After conducting a thorough evaluation of various AI technologies available on the market, SimonMed has selected Lunit INSIGHT DBT™, used in combination with Volpara Analytics™ (from Volpara Health, now a Lunit company), as its chosen solution. This best-in-class software package will now power SimonMed’s Personalized Breast Cancer Detection (PBCD) service. The PBCD service is specifically designed to offer every patient a highly precise, personalized, and data-driven breast cancer screening experience.
Enhancing Detection Accuracy and Speed Across Network
Lunit INSIGHT DBT is an FDA-cleared AI tool trained on millions of mammography images. It is engineered to identify even the most subtle indicators of breast cancer, thereby improving both the sensitivity (ability to detect cancer) and specificity (ability to rule out cancer) of screenings. Integrating this advanced AI into SimonMed’s national network, which includes over 170 accredited centers and is supported by more than 200 subspecialty-trained radiologists, is expected to facilitate earlier detection, reduce turnaround times for results, and provide more actionable insights for patients and their referring physicians.
“This is more than just an upgrade—it’s an important step forward for our patient’s health,” said Dr. Sean Raj, Chief Innovation Officer at SimonMed Imaging and Fellow of The Society of Breast Imaging (FSBI) “We’ve evaluated a range of AI technologies, and Lunit’s performance, speed, and clinical validation stood above the rest. This partnership enables us to offer the most precise and personalized mammogram experience to date—and when paired with our board-certified breast radiologists, we believe it offers the most advanced mammogram available today”
